Jeff Yass’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-260,100
Closed -$999K 14211
2026
Q1
$999K Buy
260,100
+186,000
+251% +$762K ﹤0.01% 7891
2025
Q4
$275K Buy
+74,100
New +$636K ﹤0.01% 10144
2025
Q2
Sell
-96,600
Closed -$1.07M 13423
2025
Q1
$1.07M Buy
+96,600
New +$1.15M ﹤0.01% 7098
2024
Q4
Sell
-1,220
Closed -$12.4K 12918
2024
Q3
$12.4K Buy
1,220
+507
+71% +$15.1K ﹤0.01% 11697
2024
Q2
$41.2K Sell
713
-300
-30% -$14.7K ﹤0.01% 11484
2024
Q1
$33.7K Sell
1,013
-16,140
-94% -$817K ﹤0.01% 11681
2023
Q4
$1.39M Buy
17,153
+14,166
+474% +$1.15M ﹤0.01% 6173
2023
Q3
$487K Buy
+2,987
New +$705K ﹤0.01% 8284
2023
Q2
Sell
-767
Closed -$212K 12829
2023
Q1
$212K Buy
767
+200
+35% +$73.4K ﹤0.01% 10477
2022
Q4
$219K Buy
+567
New +$160K ﹤0.01% 9891
2022
Q2
Sell
-373
Closed -$254K 13627
2022
Q1
$254K Sell
373
-394
-51% -$237K ﹤0.01% 10684
2021
Q4
$530K Buy
767
+360
+88% +$266K ﹤0.01% 9030
2021
Q3
$302K Buy
+407
New +$277K ﹤0.01% 10590

Other funds holding OM

Jeff Yass's OM Position: Q2 2026 in Review

Jeff Yass increased its Outset Medical (OM) stake by 191% in Q2 2026, buying an estimated $232K and bringing the position to 81,023 shares worth $350K. The position accounts for ﹤0.01% of the portfolio, ranked #10713.

Jeff Yass first reported a position in OM in Q3 2020 and has held it in 18 quarters since. The position peaked at $1.36M in Q2 2023. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Jeff Yass held 81,023 shares of Outset Medical worth $350K as of Q2 2026.
  • Jeff Yass bought 53,143 Outset Medical shares in Q2 2026, an estimated $232K.
  • Outset Medical made up ﹤0.01% of Jeff Yass's portfolio in Q2 2026, its #10713 holding.
  • Jeff Yass first reported a position in Outset Medical in Q3 2020 and has held it in 18 quarters since.
  • Jeff Yass's Outset Medical position peaked at $1.36M in Q2 2023.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.